Tag: Gastroenteropancreatic Neuroendocrine Tumor Therapeutics Market Size

Gastroenteropancreatic Neuroendocrine Tumor Therapeutics Market size was valued at USD 2.45 Billion in 2022 and is projected to reach USD 4.09 Billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030. Key Market Insights on Gastroenteropancreatic Neuroendocrine Tumor Therapeutics Market: Trends, Growth, and Future Prospects The gastroenteropancreatic neuroendocrine tumors (GEP-NETs) market is […]